Reuters logo
BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral
December 4, 2017 / 1:15 PM / 8 days ago

BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral

Dec 4 (Reuters) - Kindred Biosciences Inc:

* KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES

* KINDRED BIOSCIENCES INC - ‍BASED ON PRELIMINARY REVIEW OF SAFETY DATA, DRUG ZIMETA APPEARS TO BE WELL TOLERATED ​

* KINDRED BIOSCIENCES INC - CO ANTICIPATES SUBMITTING EFFECTIVENESS TECHNICAL SECTION OF NEW ANIMAL DRUG APPLICATION IN EARLY 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below